E
Evofem Biosciences Inc
OTC:EVFM
Evofem Biosciences Inc
OTC:EVFM
Price:
0.009
USD
Market Closed
Market Cap:
$1.1m
Income Statement
Earnings Waterfall
Evofem Biosciences Inc
Evofem Biosciences Inc
Income Statement
Evofem Biosciences Inc
Evofem Biosciences Inc
Currency: USD
| Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
18
N/A
|
15
-19%
|
14
-8%
|
18
+34%
|
16
-12%
|
|
| Gross Profit | ||||||
| Cost of Revenue |
(5)
|
(6)
|
(6)
|
(7)
|
(6)
|
|
| Gross Profit |
14
N/A
|
9
-34%
|
8
-16%
|
12
+54%
|
10
-13%
|
|
| Operating Income | ||||||
| Operating Expenses |
(72)
|
(51)
|
(34)
|
(30)
|
(27)
|
|
| Selling, General & Administrative |
(57)
|
(43)
|
(31)
|
(27)
|
(24)
|
|
| Research & Development |
(15)
|
(8)
|
(3)
|
(3)
|
(3)
|
|
| Operating Income |
(59)
N/A
|
(42)
+29%
|
(27)
+36%
|
(18)
+33%
|
(17)
+4%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
14
|
115
|
1
|
(2)
|
(6)
|
|
| Non-Reccuring Items |
0
|
0
|
75
|
75
|
76
|
|
| Total Other Income |
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Pre-Tax Income |
(47)
N/A
|
70
N/A
|
47
-33%
|
53
+13%
|
51
-5%
|
|
| Net Income | ||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(47)
|
70
|
47
|
53
|
51
|
|
| Net Income (Common) |
(48)
N/A
|
67
N/A
|
44
-35%
|
50
+15%
|
47
-5%
|
|
| EPS (Diluted) |
-38.06
N/A
|
42.58
N/A
|
0.05
-100%
|
0.05
N/A
|
1.52
+2 940%
|
|
Switch to:
Switch to:
See Also
Discover More
